Also trades as: SQZ (NYSE) · $vol 0M
SQZB OTC
SQZ Biotechnologies Company
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -14.3%
3Y: -74.4%
5Y: -99.8%
$0.02
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$21M
-22.4% ▼
4Y CAGR: +13.5%
Gross Profit
$10M
-39.0% ▼
4Y CAGR: -6.2%
Operating Income
-$81M
-17.3% ▼
Net Income
-$79M
-15.6% ▼
EPS (Diluted)
$-2.76
-10.8% ▼
EBITDA
-$64M
-11.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $13M | $20M | $21M | $27M | $21M |
| YoY Growth | +0.0% | +58.7% | +4.4% | +29.1% | -22.4% |
| Cost of Revenue | $0 | $0 | $0 | $11M | $12M |
| Gross Profit | $13M | $20M | $21M | $16M | $10M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 59.3% | 46.6% |
| R&D Expenses | $24M | $36M | $52M | $69M | $69M |
| SG&A Expenses | $8M | $14M | $10M | $16M | $16M |
| Operating Expenses | $32M | $50M | $72M | $85M | $86M |
| Operating Income | -$20M | -$34M | -$51M | -$69M | -$81M |
| Operating Margin | -161.1% | -170.4% | -243.2% | -253.8% | -383.7% |
| Interest Expense | $59K | $0 | $0 | $0 | $0 |
| Income Before Tax | -$19M | -$32M | -$51M | -$69M | -$79M |
| Tax Expense | $984K | $0 | $0 | $0 | $0 |
| Net Income | -$20M | -$32M | -$51M | -$69M | -$79M |
| Net Margin | -159.7% | -160.1% | -240.6% | -253.7% | -377.9% |
| EPS (Diluted) | $-0.82 | $-1.31 | $-2.04 | $-2.49 | $-2.76 |
| EBITDA | -$18M | -$30M | -$40M | -$58M | -$64M |
| Shares Outstanding | 25M | 25M | 25M | 28M | 29M |